NEW YORK, Nov. 15, 2017 /PRNewswire/ -- Potbotics, the leading data aggregation and technology company focused on the global medical cannabis market, joins The Blinc Group incubator with the goal of developing adoption and distribution strategies across the US for the first smart dose measuring vaporizer.
A key component of alternative medicine is dosing, and the process can be risky due to the inherent guesswork. Potbotics new approach allows for ultra-precise dosing according to the specific requirements of each individual patient with optimizations for micro-dosing.
Being able to analyze a patient's use over time will allow the vaporization, whether it's oil or flower, to be fully customized to their needs. This high quality vaporizing experience enables patients to accurately track how much they inhale in order to deliver consistent and predictable results.
"Blinc Groups market insights, vaporizer know how, and partnerships are a great fit to leverage the disruptive technology Potbotics has been developing for the past three years. " - David Goldstein, CEO of Potbotics.
Arnaud Dumas de Rauly, Chief Strategy Officer of The Blinc Group, said "Patients use micro-dosing for a variety of health conditions, that include seizures, autism, and cerebral palsy. Developing a dosaging device is the next big step towards consistency and pinpointing symptoms, we are very proud to be working with Potbotics on this system."
About Potbotics
Potbotics is the leading data aggregation and technology company focused on the global medical cannabis market. With a robust artificial intelligence platform that aggregates and correlates HIPAA- compliant medical data, Potbotics helps doctors and patients personalize cannabis to better predict treatment outcomes.
About The Blinc Group
The Blinc Group is a first-of-its-kind adoption and distribution-centric incubator led by a connected group of top vapor and cannabis industry experts. We create a fostering environment for the launch, expansion and funding of vapor and cannabis products.
Our mission is to build quality brands and products that innovate the face of retailers, dispensaries, head shops, and vape shops across the globe. We are invested in informing and improving public health through driving innovation and fostering rewarding consumer experiences.
We deliver full cycle support to start-ups and entrepreneurs through tailored branding, marketing, sales and engagement programs rooted in data and proprietary research. We leverage our collective expertise and network to position member companies as thought leaders in their respective industry segment and develop a foundation for scaling through the largest distribution channels in the American, European, and Asian markets.
http://www.theblincgroup.com
Contact: Arnaud Dumas de Rauly The Blinc Group [email protected] +1 (646) 586-2067
Advertisement
A key component of alternative medicine is dosing, and the process can be risky due to the inherent guesswork. Potbotics new approach allows for ultra-precise dosing according to the specific requirements of each individual patient with optimizations for micro-dosing.
Advertisement
Being able to analyze a patient's use over time will allow the vaporization, whether it's oil or flower, to be fully customized to their needs. This high quality vaporizing experience enables patients to accurately track how much they inhale in order to deliver consistent and predictable results.
"Blinc Groups market insights, vaporizer know how, and partnerships are a great fit to leverage the disruptive technology Potbotics has been developing for the past three years. " - David Goldstein, CEO of Potbotics.
Arnaud Dumas de Rauly, Chief Strategy Officer of The Blinc Group, said "Patients use micro-dosing for a variety of health conditions, that include seizures, autism, and cerebral palsy. Developing a dosaging device is the next big step towards consistency and pinpointing symptoms, we are very proud to be working with Potbotics on this system."
About Potbotics
Potbotics is the leading data aggregation and technology company focused on the global medical cannabis market. With a robust artificial intelligence platform that aggregates and correlates HIPAA- compliant medical data, Potbotics helps doctors and patients personalize cannabis to better predict treatment outcomes.
About The Blinc Group
The Blinc Group is a first-of-its-kind adoption and distribution-centric incubator led by a connected group of top vapor and cannabis industry experts. We create a fostering environment for the launch, expansion and funding of vapor and cannabis products.
Our mission is to build quality brands and products that innovate the face of retailers, dispensaries, head shops, and vape shops across the globe. We are invested in informing and improving public health through driving innovation and fostering rewarding consumer experiences.
We deliver full cycle support to start-ups and entrepreneurs through tailored branding, marketing, sales and engagement programs rooted in data and proprietary research. We leverage our collective expertise and network to position member companies as thought leaders in their respective industry segment and develop a foundation for scaling through the largest distribution channels in the American, European, and Asian markets.
http://www.theblincgroup.com
Contact: Arnaud Dumas de Rauly The Blinc Group [email protected] +1 (646) 586-2067
View original content:http://www.prnewswire.com/news-releases/potbotics-the-leading-medical-marijuana-data-aggregation-and-technology-company-joins-the-blinc-group-300556984.html
SOURCE The Blinc Group
